One of the biggest challenges in cancer treatment is chemoresistance: tumors that initially respond well to chemotherapy become resistant over time. When that happens, treatment options are often limited.
To continue reading click here
Researchers uncover mechanism by which BRCA2-deficient tumors develop chemoresistance
